spacer
spacer

PDBsum entry 4aac

Go to PDB code: 
protein ligands metals links
Transferase PDB id
4aac

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
350 a.a.
Ligands
AAV
Metals
_CL
Waters ×22
PDB id:
4aac
Name: Transferase
Title: P38alpha map kinase bound to cmpd 29
Structure: Mitogen-activated protein kinase 14. Chain: a. Synonym: map kinase 14, mapk 14, cytokine suppressive anti- inflammatory drug-binding protein, csaid-binding protein, csbp, map kinase mxi2, max-interacting protein 2, mitogen-activated protein kinase p38 alpha, map kinase p38 alpha, stress-activated protein kinase 2a, sapk2a. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Resolution:
2.50Å     R-factor:   0.234     R-free:   0.305
Authors: S.Gerhardt,D.Hargreaves
Key ref: D.S.Brown et al. (2012). The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases. Bioorg Med Chem Lett, 22, 3879-3883. PubMed id: 22608965
Date:
01-Dec-11     Release date:   16-May-12    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q16539  (MK14_HUMAN) -  Mitogen-activated protein kinase 14 from Homo sapiens
Seq:
Struc:
360 a.a.
350 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.7.11.24  - mitogen-activated protein kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
2. L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
L-seryl-[protein]
+ ATP
= O-phospho-L-seryl-[protein]
+ ADP
+ H(+)
L-threonyl-[protein]
+ ATP
= O-phospho-L-threonyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Bioorg Med Chem Lett 22:3879-3883 (2012)
PubMed id: 22608965  
 
 
The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases.
D.S.Brown, J.G.Cumming, P.Bethel, J.Finlayson, S.Gerhardt, I.Nash, R.A.Pauptit, K.G.Pike, A.Reid, W.Snelson, S.Swallow, C.Thompson.
 
  ABSTRACT  
 
No abstract given.

 

 

spacer

spacer